Robeauté raised $28 million in a Series A funding round led by Plural, Cherry Ventures, and Kindred Ventures to gain FDA approval for its microrobot designed for brain surgeries.
Robeauté raised $28 million in a Series A funding round led by Plural, Cherry Ventures, and Kindred Ventures to gain FDA approval for its microrobot designed for brain surgeries.
01/13/25, 11:21 PM
Location
parisMoney raised
$28 million
Industry
medical device
medical
biotechnology
health care
Round Type
series a
Investors
Brainlab, Apex Ventures, Think.Health, Local Globe, Kindred Ventures, Cherry Ventures, Plural
Robeauté, a Paris-based startup, has secured $28 million in venture capital funding to develop a self-propelled microrobot aimed at assisting neurosurgeons. This funding will be used to obtain FDA approval for human clinical testing targeted for 2026.
Company Info
Location
paris, ile de france, france
Additional Info
Robeauté is a Paris-based startup focused on developing self-propelled microrobots designed to operate within the human brain. Their primary goal is to assist neurosurgeons in procedures such as tissue sample collection for biopsies. The company aims to enable targeted delivery of cancer treatments and other therapeutic applications for various brain disorders. Founded in 2017, Robeauté combines advanced robotics with medical needs to create groundbreaking solutions in neurosurgery.